Rubedo Life Sciences
PrivateLast Round
Series A
Apr 22, 2024
Total Funding Raised
$53.45M
Company Overview
Rubedo Life Sciences is a biopharmaceutical company that develops therapies for chronic age-related diseases by targeting senescent cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rubedo Life Sciences Comparables
Compare Rubedo Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deciduous Therapeutics | 89% | |
| Cleara Biotech | 84% | |
| StarkAge Therapeutics | 82% |
Rubedo Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 22, 2024 | ||||
| Grant | Feb 6, 2023 | ||||
| Seed | Dec 3, 2020 |
Key People
Founding team and executive leadership
Rubedo Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed, Series A |
| Khosla Ventures | Seed, Series A |
| age1 | Seed |
| Hevolution Foundation | Series A |
| LongeVC | Series A |
| Longevity Fund | Seed |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2025
First patient dosed in Phase 1 trial for RLS-1496.
- Jan 1, 2025
Presented at the 12th Annual Dermatology Summit.
Rubedo Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rubedo Life Sciences's valuation, stock price, and market status.
Is Rubedo Life Sciences a public or private company?
Rubedo Life Sciences is a private company.
What is the current stock price of Rubedo Life Sciences?
Rubedo Life Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is Rubedo Life Sciences worth (valuation)?
Valuation information for Rubedo Life Sciences is not publicly available.
Can I buy Rubedo Life Sciences stock?
Rubedo Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rubedo Life Sciences's last funding round?
Rubedo Life Sciences's most recent funding round was Series A on April 22, 2024.
Who are the main investors in Rubedo Life Sciences?
Key investors in Rubedo Life Sciences include Khosla Ventures, Ahren Innovation Capital.
Will Rubedo Life Sciences IPO soon?
No public IPO plans have been announced for Rubedo Life Sciences.
How can I track Rubedo Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rubedo Life Sciences's secondary market activity and sign up for updates.